Testing effectiveness (Phase 2)Study completedNCT00159250
What this trial is testing
Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
Who this might be right for
Duchenne Muscular Dystrophy
Imperial College London 7